CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,511,068
+$1,272,509 QoQ
Shares Held
323,451
-0.3% QoQ
Ownership
0.608%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. KALV ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,511,068 | 323,451 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,238,559 | 324,369 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,921,558 | 321,967 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,283,072 | 113,496 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,305,450 | 113,124 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $849,947 | 100,348 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,282,137 | 110,720 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,302,797 | 110,594 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $926,716 | 78,138 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $985,524 | 80,451 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $627,433 | 65,154 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $586,386 | 65,154 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $501,994 | 63,867 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $426,664 | 63,116 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $915,813 | 63,116 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $618,926 | 62,899 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $861,037 | 58,415 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $759,600 | 57,415 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $909,110 | 52,098 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,153,937 | 48,161 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,204,783 | 46,897 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $637,817 | 33,587 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $390,164 | 30,990 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $392,294 | 32,421 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $228,191 | 29,829 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||